Company intelligence / Profile preview

BLUMORPHO

Ownership: Private
Employees: ~15
Development stage: Other

Overview

BLUMORPHO is a European innovation agency and venture builder specializing in deep tech and smart systems, with a significant focus on the healthcare and medical device sectors. The company facilitates the transition of disruptive technologies from research to market by connecting startups, research organizations, and industrial leaders. Their service portfolio includes innovation management, business development support, and strategic consulting to accelerate the commercialization of MedTech and digital health solutions. BLUMORPHO also operates as an ecosystem builder, organizing international challenges and investment forums to foster high-tech entrepreneurship.

Industry: Investors

Partnerships

CEA-LetiEuropean CommissionEIT HealthSilicon Europe

Beyond the preview

Go deeper on BLUMORPHO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BLUMORPHO.

Explore the full profile